Biomarkers to Enhance Early Schizophrenia Treatment

Clinical trial NCT06969755 · RECRUITING

Trial details

NCT number: NCT06969755
Sponsor: Northwell Health
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophenia Disorder

Start date: 2024-09-04
Primary completion: 2030-07-30
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.